Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Calithera Biosciences stock (CALA)

Buy Calithera Biosciences stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Calithera Biosciences is a biotechnology business based in the US. Calithera Biosciences shares (CALA) are listed on the PINK and all prices are listed in US Dollars. Calithera Biosciences employs 8 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Calithera Biosciences stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Calithera Biosciences stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CALA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Calithera Biosciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Not rated yet
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Cash App
Finder Score: 3 / 5: ★★★★★
Cash App
Stocks, ETFs, Cryptocurrency
Buy and sell over 1,800 stocks and ETFs commission-free and for as little as $1.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Calithera Biosciences stock price (PINK: CALA)

Use our graph to track the performance of CALA stocks over time.

Calithera Biosciences shares at a glance

Information last updated 2024-07-14.
Latest market close$0.01
52-week range$0.01 - $0.08
50-day moving average $0.02
200-day moving average $0.03
Wall St. target price$5.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-7.94

Calithera Biosciences price performance over time

Historical closes compared with the close of $0.0125 from 2024-07-18

1 week (2024-07-12) 25.00%
1 month (2024-06-18) 0.0125
3 months (2024-04-19) -50.00%
6 months (2024-01-19) -60.06%
1 year (2023-07-19) -75.00%
2 years (2022-07-19) -99.55%
3 years (2021-07-19) 1.98
5 years (2019-07-19) 4.12

Calithera Biosciences financials

Gross profit TTM $-42,705,000
Return on assets TTM -56.29%
Return on equity TTM -114.14%
Profit margin 0%
Book value $-0.40
Market Capitalization $170,537

TTM: trailing 12 months

Calithera Biosciences share dividends

We're not expecting Calithera Biosciences to pay a dividend over the next 12 months.

Have Calithera Biosciences's shares ever split?

Calithera Biosciences's shares were split on a 1:20 basis on 14 June 2022. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Calithera Biosciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Calithera Biosciences shares which in turn could have impacted Calithera Biosciences's share price.

Calithera Biosciences share price volatility

Over the last 12 months, Calithera Biosciences's shares have ranged in value from as little as $0.01 up to $0.082. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Calithera Biosciences's is -0.238. This would suggest that Calithera Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Calithera Biosciences has bucked the trend.

Calithera Biosciences overview

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California. .

Frequently asked questions

What percentage of Calithera Biosciences is owned by insiders?
Currently 1.074% of Calithera Biosciences shares are held by insiders.
How many people work for Calithera Biosciences?
Latest data suggests 8 work at Calithera Biosciences.
When does the fiscal year end for Calithera Biosciences?
Calithera Biosciences's fiscal year ends in December.
Where is Calithera Biosciences based?
Calithera Biosciences's address is: 343 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
What is Calithera Biosciences's ISIN number?
Calithera Biosciences's international securities identification number is: US13089P5070
What is Calithera Biosciences's CUSIP number?
Calithera Biosciences's Committee on Uniform Securities Identification Procedures number is: 13089P101

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site